Paul Lane retweeted
Envision Pharma Group announces the successful implementation of iEnvision to connect and support Otsuka’s medical affairs activities bit.ly/2Kzk2hl #iEnvision @OtsukaUS
Paul Lane retweeted
Yet another publication with patient co-authors (how many pubs are req'd before people stop questioning whether patients can be authors???) & rationale for plain language summaries of research! #GPP4 bmjopen.bmj.com/content/8/5/…
Paul Lane retweeted
CAR-T cell immunotherapy - a promising new #cancertreatment. Listen to this exclusive interview with #immunology pioneer Dr Carl June of @PennMedicine @Penn @Penncancer goo.gl/5wYiuw #leukemia #cancer #newincancer #breakthrough #FDA @grpetersen1 @JackMAiello @parkerici
Paul Lane retweeted
The new Concise Guide to PHARMACOLOGY 2017/18 is now available online: buff.ly/2BWDsZ8
Paul Lane retweeted
Voter Identification Laws and Turnout in the United States, 2017 Annual Review of #PoliSci arevie.ws/2nWdLoJ
Paul Lane retweeted
BREAKING: The FCC’s Republican majority has voted to repeal so-called "net neutrality" rules. n.pr/2j6za9f
Paul Lane retweeted
Researchers are studying an ice core sample as tall as the #empirestatebuilding that contains ice from the Stone Age, more than 600,000 years ago... bit.ly/2j4S5Bv#NSFfunded Image credit: @ByrdPolar
Paul Lane retweeted
Offering both green OA link & DOI to version of record in same citation is an interesting approach. Will it become a referencing standard? teapawt.net/emcandre/status/901104… – at Manhattan, NY
Wikipedia now displays which sources are #OpenAccess so the Wiki curious can click thru to read more #ResearchImpact
strathoa.tumblr.com/post/163…
Paul Lane retweeted
Combining cancer treatments increases their power, helping people live longer and healthier lives #WeWontRest ow.ly/crQE30eh9wZ
Paul Lane retweeted
NEW free tool to help Japan's Datavision users (more every day) prep for publication audits. Pick up copy #ISMPPAP17 @EnvisionPharma stand
Paul Lane retweeted
Have you tried @unpaywall extension yet? It can help you find open access articles with ease. Ask us for more info! buff.ly/2wrxQXj
Paul Lane retweeted
Peace at Last? – Final Guidance on Lay Summaries of Clinical Study Results Released clinicaltrialsarena.com/news…
Paul Lane retweeted
FDA decisions & COI "We found no association between the
prevalence of section 502 conflicts and voting outcomes" jamanetwork.com/journals/jam…
Paul Lane retweeted
Want a great place for #Neurology videos? Our YouTube channel is the site for you! ow.ly/6R5830eo21H
Paul Lane retweeted
JAMA revisits Medical Writing - any violent allergic reactions to poor writing? @ISMPP @AmMedWriters @Official_EMWA tinyurl.com/ycq2vwua
Paul Lane retweeted
Paywall: The Business of Scholarship:
vimeo.com/217495703
#openscience #openaccess #openresearch #opendata
Paul Lane retweeted
Check out this real-time impact analysis of health professions education research using #altmetrics @LaurenMaggio ow.ly/Fsxe30eAnwK
Paul Lane retweeted
#ISPOR welcomes two new chapters, India-Amaravati Chapter and Ethiopia Chapter! View chapters around the world at ispor.org/RegionalChapters.
Paul Lane retweeted
ChemRxiv, a new chemistry preprint server for the global chemistry community, is now available:
researchinformation.info/pro… #openaccess
Paul Lane retweeted
New blog post! The missing piece: using Altmetric to complete the puzzle - insights into analysing engagement: ow.ly/ftpD30etrnf


























